GBp 8.25
(-4.07%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -236.16 Thousand | -152.14 Thousand | -163.29 Thousand | -236.05 Thousand | - |
Net Income | -242.53 Thousand | -159.47 Thousand | -172.76 Thousand | -207.61 Thousand | - |
Depreciation & Amortization | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 6362.00 | 7334.00 | 9462.00 | -28.44 Thousand | - |
Other non-cash items | -11.05 Thousand | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Investments in PPE | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - |
Financing Cash Flow | 192.72 Thousand | - | - | 537.13 Thousand | - |
Debt repayment | -192.72 Thousand | - | - | -10.46 Thousand | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | 526.66 Thousand | - |
Other Financing Activities | 192.72 Thousand | - | - | 10.46 Thousand | - |
Accounts receivables | 11.05 Thousand | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | -4697.00 | - | - | -28.44 Thousand | - |
Cash at beginning of period | 48.21 Thousand | 200.35 Thousand | 363.65 Thousand | 62.57 Thousand | - |
Cash at end of period | 4767.00 | 48.21 Thousand | 200.35 Thousand | 363.65 Thousand | - |
Capital Expenditure | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -43.44 Thousand | -152.14 Thousand | -163.29 Thousand | 301.07 Thousand | - |
Free Cash Flow | -236.16 Thousand | -152.14 Thousand | -163.29 Thousand | -236.05 Thousand | - |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -3.3 Million | -242.53 Thousand | -170.89 Thousand | -71.63 Thousand | -90.92 Thousand | -159.47 Thousand |
Depreciation & Amortization | 44.13 Thousand | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.11 Million | 6362.00 | -21.73 Thousand | 28.1 Thousand | 24.96 Thousand | 7334.00 |
Other non-cash items | 627.94 Thousand | -11.05 Thousand | -11.29 Thousand | 239.00 | 1.00 | - |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | -2.00 | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 1.79 Million | 192.72 Thousand | 192.72 Thousand | - | - | - |
Debt repayment | -1.38 Million | -192.72 Thousand | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 427.46 Thousand | - | - | - | - | - |
Other Financing Activities | -23.06 Thousand | 192.72 Thousand | 192.72 Thousand | - | - | - |
Accounts receivables | -41.53 Thousand | 11.05 Thousand | 11.29 Thousand | -239.00 | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 1.15 Million | -4697.00 | -33.03 Thousand | 28.34 Thousand | 20.15 Thousand | - |
Cash at beginning of period | 4767.00 | 48.21 Thousand | 4674.00 | 48.21 Thousand | 114.17 Thousand | 200.35 Thousand |
Cash at end of period | 287.31 Thousand | 4767.00 | 4767.00 | 4674.00 | 48.21 Thousand | 48.21 Thousand |
Capital Expenditure | -2.00 | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 282.54 Thousand | -43.44 Thousand | 93.00 | -43.53 Thousand | -65.96 Thousand | -152.14 Thousand |
Free Cash Flow | -1.51 Million | -236.16 Thousand | -192.63 Thousand | -43.53 Thousand | -65.96 Thousand | -152.14 Thousand |
FVJ
NEULANDLAB
AZZTF
GWIN
1463
NIVAKA